- 5-Fluoroisatin
-
- $0.00 / 1kg
-
2026-04-24
- CAS:443-69-6
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: Customise
- 5-Fluoroisatin
-
- $29.00 / 200mg
-
2026-04-20
- CAS:443-69-6
- Min. Order:
- Purity: 97.71%
- Supply Ability: 10g
- 5-Fluoroisatin
-
- $29.00 / 200mg
-
2026-04-20
- CAS:443-69-6
- Min. Order:
- Purity: 97.71%
- Supply Ability: 10g
|
| | 5-Fluoroisatin Basic information |
| | 5-Fluoroisatin Chemical Properties |
| Melting point | 224-227 °C (lit.) | | density | 1.477±0.06 g/cm3(Predicted) | | storage temp. | Sealed in dry,Room Temperature | | solubility | Chloroform, DMSO, Methanol | | form | Powder | | pka | 8.51±0.20(Predicted) | | color | Red | | BRN | 131241 | | InChI | InChI=1S/C8H4FNO2/c9-4-1-2-6-5(3-4)7(11)8(12)10-6/h1-3H,(H,10,11,12) | | InChIKey | GKODDAXOSGGARJ-UHFFFAOYSA-N | | SMILES | N1C2=C(C=C(F)C=C2)C(=O)C1=O | | CAS DataBase Reference | 443-69-6(CAS DataBase Reference) |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-37/39-36 | | WGK Germany | 3 | | HazardClass | IRRITANT | | HS Code | 29337900 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 |
| | 5-Fluoroisatin Usage And Synthesis |
| Chemical Properties | red Crystalline Powder | | Uses | It showed antibacterial and antifungal activities. | | Uses | Reactant for preparation of:
- Spiro[indole-thiazolidinones] as biologically relevan synthesis scaffolds
- Potential antimycobacterial agents
- Inhibitors of c-Met kinase
- Inhibitors of TAK1 kinase
- Herpes simplex virus inhibitors
- IKKβ inhibitors
- Inhibitors of vitiligo disease
- Potential drug candidates with anti-HIV activity and anti-tubercular activity
| | Definition | ChEBI: 5-Fluoroisatin is a member of indoles. It has a role as an anticoronaviral agent. | | General Description | 5-Fluoroisatin has been reported as the precursor of the Sunitinib (Sutent) drug. 5-Fluoroisatin has been approved by the Food and Drugs Administration (FDA) in 2006 for the treatment of renal cell carcinoma (RCC) and gastrointestinal stromal tumor (GIST). | | Synthesis | Concentrated sulfuric acid (24.0 mL) was added to a dry 150 mL three-necked flask and heated to 50 °C. The intermediate synthesized above (2a-2d, 30.0 mmol) was slowly added and the color of the solution gradually deepened to black as the intermediate was added. After the addition was completed, the reaction temperature was raised to 80 °C and the reaction was maintained for 20 min. Subsequently, crushed ice (100 g) was slowly added to the reaction system, at which time the ice-water mixture showed a reddish brown color. After standing, the reaction mixture was filtered and washed with deionized water until neutral. The resulting solid was dissolved in 10.0% NaOH solution (90 mL), the pH was adjusted to 4 with concentrated hydrochloric acid and filtered. The filtrate was continued to adjust the pH to 2 with concentrated hydrochloric acid, at which time a large amount of brick red solid precipitated. The solid was collected by filtration and dried to give the reddish brown target products 3a-3d. (Elution conditions: petroleum ether: ethyl acetate, v/v = 1:2, Rf = 0.4-0.6). | | References | [1] Patent: CN107033064, 2017, A. Location in patent: Paragraph 0050; 0051; 0052; 0053 [2] Journal of the Brazilian Chemical Society, 2019, vol. 30, # 1, p. 198 - 209 [3] Synthetic Communications, 1999, vol. 29, # 20, p. 3627 - 3633 [4] Medicinal Chemistry, 2016, vol. 12, # 5, p. 489 - 498 [5] Journal of Heterocyclic Chemistry, 2018, vol. 55, # 12, p. 2919 - 2928 |
| | 5-Fluoroisatin Preparation Products And Raw materials |
|